Clinical Service Lines
The AGA has developed clinical service lines (CSL) to support practices in delivering high quality, cost-efficient care to patients. Each CSL is unique for each condition and links evidence-based guidelines, measures and the AGA Digestive Health Outcomes Registry®, along with other practice management tools, in a single toolkit that can be easily accessed at the bedside, office, facility or other setting.
Inflammatory Bowel Disease
The care of patients with inflammatory bowel disease (IBD) is an important part of the practice of gastroenterology. The resources included in the IBD CSL can be used by practices to assist in the management of patients with IBD through robust performance measurement and population management tools designed to promote collaborative care between the primary care provider, the specialist, and the patient.
In the United States, hepatitis C virus (HCV) infection accounts for approximately 40 percent of all chronic liver disease, results in an estimated 8000–10,000 deaths annually, and is the most frequent indication for liver transplantation. Of the 3–4 million persons with HCV, only approximately half a million have been treated, and the majority have not been identified. The resources in the HCV CSL are designed to assist practices in improving the screening and treatment of patients with HCV.
In the United States, colorectal cancer (CRC) is the third most common cancer diagnosed among men and women and the second leading cause of death from cancer. The resources included in the CRC CSL can assist practices in screening for and managing patients with CRC. Tools were developed to assist practices in delivering high-quality, cost-efficient care and promoting cross-speciality collaboration.